Haviv, Doron
Remšík, Ján http://orcid.org/0000-0002-3228-2896
Gatie, Mohamed http://orcid.org/0000-0001-8500-5609
Snopkowski, Catherine
Takizawa, Meril
Pereira, Nathan
Bashkin, John
Jovanovich, Stevan http://orcid.org/0000-0002-3285-1091
Nawy, Tal http://orcid.org/0000-0003-3720-3699
Chaligne, Ronan http://orcid.org/0000-0003-4332-3291
Boire, Adrienne
Hadjantonakis, Anna-Katerina
Pe’er, Dana http://orcid.org/0000-0002-9259-8817
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA209975, DK127821, CA233284)
Article History
Received: 18 April 2023
Accepted: 28 February 2024
First Online: 2 April 2024
Competing interests
: D.P. is a member of the scientific advisory board of and has equity in Insitro. A.B. holds an unpaid position on the scientific advisory board of Evren Scientific and is an inventor on patents 62/258,044, 10/413,522 and 63/052,139 filed by Memorial Sloan Kettering Cancer Center. A.B. and J.R. are inventors of provisional patent applications 63/449,817 and 63/449,823 filed by Memorial Sloan Kettering Cancer Center. J.B., S.J. and N.P. were employees of S2 Genomics during this work and own company stock. The other authors declare no competing interests.